AIV Logo AIV Assistant

Loading...

 Logo GeneDx Holdings Corp. Class A Common Stock - WGS Open GeneDx Holdings Corp. Class A Common Stock in new tab

131.50
P/E
1610.88
EPS
0.08
P/B
13.35
ROE
0.01
Beta
2.04

131.5000

131.500

Daily: -0.20%
Key Metrics

Earnings date: Feb. 17, 2026

P/E: 1610.88

EPS: 0.08

Book Value: 9.65

Price to Book: 13.35

Debt/Equity: 41.27

% Insiders: 0.123%

Growth

Revenue Growth: 0.46%

Estimates

Forward P/E: 263.00

Forward EPS: 0.49

 Logo About GeneDx Holdings Corp. Class A Common Stock - (WGS)

Country: United States

Sector: Information Technology

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion